The upregulated expression of FUT8 has been reported in several cancers, including lung cancer [6], prostate cancer [7], hepatocellular carcinoma (HCC) [8–10] and CRC [11], demonstrating that FUT8 is involved in biological tumor characteristics and patient outcomes. Here, FUT8 is linked to lung carcinoma.